Achillion Pharmaceuticals, Inc. (ACHN)
-NasdaqGS 2.88 
0.23(8.68%) 4:00PM EDT|After Hours
:
2.90 0.02 (0.69%) 7:51PM EDT
| Prev Close: | 2.65 |
|---|
| Open: | 2.72 |
|---|
| Bid: | 2.60 x 5000 |
|---|
| Ask: | 3.00 x 300 |
|---|
| 1y Target Est: | 7.19 |
|---|
| Beta: | 2.05 |
|---|
| Next Earnings Date: | 4-Nov-13 |
|---|
| Day's Range: | 2.67 - 2.94 |
|---|
| 52wk Range: | 2.62 - 11.36 |
|---|
| Volume: | 7,436,223 |
|---|
| Avg Vol (3m): | 2,024,520 |
|---|
| Market Cap: | 278.33M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.69 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why a Backup Plan Is No Plan at Allat Motley Fool(Tue, Oct 1)
- STOCK NEWS US -Total option open interest rises by 4.73 mln contractsReuters(Tue, Oct 1)
- Is Achillion a Bad News Buy Post-Bloodbath?at Motley Fool(Tue, Oct 1)
- Pulling the Plug on Achillionat TheStreet(Tue, Oct 1)
- 4 Stocks Making Movesat Motley Fool(Mon, Sep 30)
- Setback for AchillionZacks(Mon, Sep 30)
- Wolf Haldenstein Announces Investigation of Achillion Pharmaceuticals Inc.Business Wire(Mon, Sep 30)
- LDK Solar and Panera are big market moversAP(Mon, Sep 30)
- LDK Solar and Intel are big market moversAP(Mon, Sep 30)
- [video] The Top Ten Stocks for Sept. 30at Bloomberg(Mon, Sep 30)
- Monday Closing Bell: Markets Softer as Shutdown Looms24/7 Wall St.(Mon, Sep 30)
- FDA Holds, Achillion Foldsat Motley Fool(Mon, Sep 30)
- Analysts: Due Diligence May Hurt BlackBerry and 3 Other Research Notes to Browseat Wall St. Cheat Sheet(Mon, Sep 30)
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Achillion Pharmaceuticals, Inc. - ACHNPR Newswire(Mon, Sep 30)
- Achillion Pharmaceuticals, Inc. - Special Callat Seeking Alpha(Mon, Sep 30)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2,170.35 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.73 |
|---|
| Quarterly EPS Est
(Sep-13)
: | -0.20 |
|---|
| Mean Recommendation*: | 2.8 |
|---|
| PEG Ratio (5 yr expected): | -0.79 |
|---|
Business Summary
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.
View More